Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure.

John J.V. McMurray,David C. Wheeler,Bergur V. Stefansson,Niels Jongs,Douwe Postmus,Ricardo Correa-Rotter,Glenn M. Chertow,Fan Fan Hou,Peter Rossing,C. David Sjöström,Scott D. Solomon,Robert D. Toto,Anna Maria Langkilde,Hiddo J.L. Heerspink,Dapa-Ckd Trial Committees,Investigators

Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure.

2021

John J.V. McMurray
David C. Wheeler
Bergur V. Stefansson
Niels Jongs
Douwe Postmus
Ricardo Correa-Rotter
Glenn M. Chertow
Fan Fan Hou
Peter Rossing
C. David Sjöström
Scott D. Solomon
Robert D. Toto
Anna Maria Langkilde
Hiddo J.L. Heerspink
Dapa-Ckd Trial Committees
Investigators

Abstract Objectives The purpose of this paper was to investigate the effects of dapagliflozin in chronic kidney disease (CKD) patients, with and without heart failure (HF). Background Patients with...

Keywords:

Internal medicine
in patient
Kidney disease
Heart failure
Medicine
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Dapagliflozin
2019 20 coronavirus outbreak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations